Madrigal Pharmaceuticals, Inc. announced an exclusive global licensing agreement to introduce six preclinical-stage siRNA (small interfering RNA) programs, aiming to significantly expand its research and development pipeline for metabolic dysfunction-associated steatohepatitis (MASH).

老虎证券2026/02/11 10:07

Show original

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Fourth attempt finally approved! Brookfield (BAM.US) acquires Australian pipeline products manufacturer RWC for $2.9 billion, a 32% premium

Brookfield Asset Management has agreed to acquire Reliance Worldwide Corp. in an all-cash deal, valuing the Australian plumbing products company at approximately 4.1 billion Australian dollars (about 2.9 billion US dollars).

智通财经•2026/09/16 02:41

Spot Gold Surpasses $4,300 per Ounce, Up 0.16% for the Day

Cointime•2026/09/16 02:36

Hyundai Mobis' Earnings Could Be Dragged Lower by Stronger Won -- Market Talk

Dow Jones•2026/09/16 02:35

Japan Capex Outlook Solid on AI Demand, Economic Policy Hopes -- Market Talk

Dow Jones•2026/09/16 02:17